NO20002293L - FremgangsmÕte til fremstilling av særdeles virusfrie komponenter til Õ danne fibrinlim fra humant blodplasma - Google Patents

FremgangsmÕte til fremstilling av særdeles virusfrie komponenter til Õ danne fibrinlim fra humant blodplasma

Info

Publication number
NO20002293L
NO20002293L NO20002293A NO20002293A NO20002293L NO 20002293 L NO20002293 L NO 20002293L NO 20002293 A NO20002293 A NO 20002293A NO 20002293 A NO20002293 A NO 20002293A NO 20002293 L NO20002293 L NO 20002293L
Authority
NO
Norway
Prior art keywords
viral
thrombin
recovery
product
virus
Prior art date
Application number
NO20002293A
Other languages
English (en)
Other versions
NO20002293D0 (no
NO323299B1 (no
Inventor
Trung Bui-Khac
Original Assignee
Haemacure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemacure Corp filed Critical Haemacure Corp
Publication of NO20002293D0 publication Critical patent/NO20002293D0/no
Publication of NO20002293L publication Critical patent/NO20002293L/no
Publication of NO323299B1 publication Critical patent/NO323299B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
NO20002293A 1997-10-30 2000-04-28 Fremgangsmate til fremstilling trombin NO323299B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,660 US5981254A (en) 1997-10-30 1997-10-30 Process for producing thrombin from plasma
PCT/CA1998/001008 WO1999023111A1 (en) 1997-10-30 1998-10-29 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma

Publications (3)

Publication Number Publication Date
NO20002293D0 NO20002293D0 (no) 2000-04-28
NO20002293L true NO20002293L (no) 2000-06-30
NO323299B1 NO323299B1 (no) 2007-03-05

Family

ID=25503448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002293A NO323299B1 (no) 1997-10-30 2000-04-28 Fremgangsmate til fremstilling trombin

Country Status (16)

Country Link
US (1) US5981254A (no)
EP (1) EP1027371B1 (no)
JP (1) JP4278861B2 (no)
AT (1) ATE305011T1 (no)
AU (1) AU759145B2 (no)
CA (1) CA2307380A1 (no)
DE (1) DE69831684T2 (no)
DK (1) DK1027371T3 (no)
ES (1) ES2249843T3 (no)
IL (1) IL135812A (no)
IN (1) IN185759B (no)
NO (1) NO323299B1 (no)
NZ (1) NZ504246A (no)
PL (1) PL194589B1 (no)
RU (1) RU2236237C2 (no)
WO (1) WO1999023111A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
CA2394797A1 (en) * 1999-12-20 2001-06-28 Tsuyoshi Takahashi Process for producing virus-free plasma protein composition by porous membrane treatment, virus-free plasma protein composition and method of removing viruses
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
NZ518692A (en) * 1999-12-23 2004-08-27 Csl Ltd Purified fibrinogen free of destabilising levels of plasminogen and other proteases obtained from a Fraction I paste
JP2002114799A (ja) * 2000-08-01 2002-04-16 Nihon Pharmaceutical Co Ltd ウイルス除去方法
US7411006B2 (en) 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US7217507B2 (en) * 2002-04-15 2007-05-15 The American National Red Cross Method for detecting ligands and targets in a mixture
US20060275829A1 (en) * 2002-04-15 2006-12-07 Hammond David J Combinatorial library for proteomic investigations
US20060275753A1 (en) * 2002-04-15 2006-12-07 Hammond David J Recovery of analytes using combinatorial libraries
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
WO2004011023A1 (de) * 2002-07-23 2004-02-05 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfähige und thrombinhältige pharmazeutische wirkstoffzubereitungen und arzneimittel
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
EP1711513B1 (en) 2003-12-01 2014-07-02 Novo Nordisk Health Care AG Nanofiltration of factor vii solutions to remove virus
ES2395466T3 (es) * 2004-06-22 2013-02-12 Zymogenetics, Inc. Composiciones de trombina
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120195953A1 (en) * 2007-09-19 2012-08-02 Kieu Hoang Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
GB0814570D0 (en) * 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
CN104703612B (zh) * 2012-09-26 2021-03-19 骨治疗公司 包含溶剂/去污剂处理过的血浆(s/d血浆)的制剂及其用途
RU2583931C2 (ru) * 2014-06-11 2016-05-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата тромбина
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
JP6666757B2 (ja) * 2016-03-10 2020-03-18 日本メジフィジックス株式会社 ポリオキシエチレン系非イオン界面活性剤の定量方法及び放射性医薬品製剤の製造方法
CA3091348A1 (en) * 2018-02-19 2019-08-22 Bayer Healthcare Llc Modified filter membrane and method
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface
CN113754757A (zh) * 2021-07-01 2021-12-07 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
WO2023020914A1 (en) 2021-08-18 2023-02-23 Biotest Ag Dry heat treatment of plasma-derived factor viii
KR20230121373A (ko) * 2022-02-11 2023-08-18 주식회사 녹십자 인자 xiii의 정제방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography

Also Published As

Publication number Publication date
EP1027371A1 (en) 2000-08-16
ATE305011T1 (de) 2005-10-15
CA2307380A1 (en) 1999-05-14
DK1027371T3 (da) 2006-01-09
IN185759B (no) 2001-04-21
JP2001521941A (ja) 2001-11-13
PL340300A1 (en) 2001-01-29
DE69831684D1 (de) 2006-02-02
AU9731698A (en) 1999-05-24
IL135812A (en) 2007-09-20
US5981254A (en) 1999-11-09
ES2249843T3 (es) 2006-04-01
WO1999023111A1 (en) 1999-05-14
DE69831684T2 (de) 2006-06-22
RU2236237C2 (ru) 2004-09-20
PL194589B1 (pl) 2007-06-29
NO20002293D0 (no) 2000-04-28
NZ504246A (en) 2002-09-27
NO323299B1 (no) 2007-03-05
JP4278861B2 (ja) 2009-06-17
EP1027371B1 (en) 2005-09-21
AU759145B2 (en) 2003-04-03
IL135812A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
NO20002293D0 (no) FremgangsmÕte til fremstilling av særdeles virusfrie komponenter til Õ danne fibrinlim fra humant blodplasma
RU2000113224A (ru) Способ продуцирования в высокой степени вирусобезопасных компонентов для получения фибринового клея из пула плазмы человека
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
NO963602D0 (no) Fremgangsmåte for å oppta et biologisk klebemiddel som er laget av konsentrerte koagulasjonsfaktorer ved utsalting
ES2184594A1 (es) Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP0125520A3 (en) A process and a plant for the recovery of one or more constituents from a gas mixture
JPH04243899A (ja) 第ｖｉｉｉ因子の精製およびこの方法で得られた第ｖｉｉｉ因子
DE3432083A1 (de) Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
JPH0348888B2 (no)
ES2051686T3 (es) Metodo para preparar factor antihemofilico (ahf) por precipitacion en frio y para mejorar la solubilidad del producto de ahf recuperado.
JPH05227983A (ja) 米糠蛋白誘導ペプチドの製造方法
ATE233576T1 (de) Wärmebehandlung von blutplasmaproteinen
NO307473B1 (no) Fremgangsmõte for fremstilling av et pasteurisert trombinkonsentrat
Porter et al. Photocoagulation of human plasma: acyl serine proteinase photochemistry
BR9611363A (pt) Processo e aparelho de destilação osmótica.
CA2277406A1 (en) Production of protein preparations with a reduced aggregate content
JPH1052267A (ja) プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
SK281266B6 (sk) Spôsob získavania enzýmov z proenzýmov
US3711376A (en) Coagulants
EP0237981A3 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII enthaltenden, sterilen Präparates
NO20000621D0 (no) FremgangsmÕte for fremstilling av kontrastmiddel
JPS589686A (ja) ス−パ−オキサイドジスムタ−ゼの精製法
JPH0272874A (ja) イネモミガラパーオキシターゼの製造方法
SU1564190A1 (ru) Способ получени препарата фотосинтетических реакционных центров, содержащих фотоактивные цитохромы
EP0238986A3 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII in ankonzentrierter Form enthaltenden Präparates

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees